Search results
Factbox-Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimer's drug
Reuters via Yahoo Canada News· 3 hours agoKisunla is now the second drug to get a traditional approval from the U.S. regulator for the...
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
Insider Monkey via Yahoo Finance Canada· 23 hours agoClearBridge Investments, an investment management company, released its “ClearBridge Value Equity...
FDA approves new Alzheimer’s drug that slows memory decline - National | Globalnews.ca
Global B.C.· 3 hours ago“This is real progress,” said Joanne Pike of the Alzheimer’s Association. Like Eisai 4523.T and Biogen’s BIIB.O rival drug Leqembi, which was approved a year ago, donanemab ...
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters via Yahoo Finance Canada· 6 days agoLeqembi, which works by removing a toxic protein called beta amyloid from the brain, is the first...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance Canada· 3 hours agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
FDA approves a second Alzheimer's drug that can modestly slow disease
The Canadian Press via Yahoo Finance Canada· 18 hours agoWASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the...
FDA Approves Eli Lilly’s Alzheimer’s Drug
Barrons.com· 20 hours agoThe drug works by attacking brain plaques made up of clumps of proteins known as amyloids. It is similar to Leqembi, an Alzheimer’s medicine from Biogen...
FDA Approves New Alzheimer's Drug, Adding a New Option for Treatment
Men's Journal· 19 hours agoIt's the second to receive FDA approval. Alzheimer's disease affects millions of Americans as well...
New Drug Approved for Early Alzheimer’s
New York Times· 22 hours agoThe drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the...
Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
Zacks via Yahoo Finance Canada· 5 days agoThe pipeline progress has been encouraging. DNLI has collaborations with bigwigs like Biogen BIIB...
